Age-Related Macular Degeneration

DENVER — Omega-3 fatty acid supplements may improve vision in patients with dry age-related macular degeneration and Stargardt disease, according to a study.

DENVER — In this Healio Video Perspective from the ARVO meeting, Jason S. Slakter, MD, discusses his poster on phase 2b study results of OPT-302 (Opthea) in combination with ranibizumab for wet age-related macular degeneration.

In this edition, European commission approves Beovu for DME, choroidal vascularity index linked with geographic atrophy progression and more.

WASHINGTON — Age-related macular degeneration has a significant impact on vision across the population, according to a speaker here.

In this edition, digital imaging and AI advance investigation of systemic disease through the retina; handheld retinal imaging devices may have utility in screening; Xipere launches in the US; and more.

This week, a speaker predicts the AMD epidemic will continue to challenge ophthalmologists; pegcetacoplan results in 18-month reduction in GA lesion growth; interim trial results show efficacy of photobiomodulation in dry AMD; and more.

The Port Delivery System with ranibizumab was noninferior and had similar efficacy to monthly ranibizumab injections for the treatment of neovascular age-related macular degeneration, according to results from the Archway trial.

Soft drusen and subretinal drusenoid deposits have distinguishing characteristics and may represent separate diseases processes that lead to age-related macular degeneration, according to a prospective study.

LumiThera reported positive findings in the LIGHTSITE III clinical trial evaluating the safety and efficacy of photobiomodulation with the Valeda light delivery system as a treatment for dry age-related macular degeneration.

Women appear to have a higher risk for developing age-related macular degeneration, but the reason for this remains unclear, according to Rishi P. Singh, MD.